Evidence map›Paper›PMID 30702344›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2019

Genetic inactivation of the phospholipase A

José Pablo Vázquez-Medina, Jian-Quin Tao, Priyal Patel, Renata Bannitz-Fernandes, Chandra Dodia, Elena M Sorokina, Sheldon I Feinstein, Shampa Chatterjee, Aron B Fisher

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Phospholipases: Where Do We Stand?Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. The Role of Peroxiredoxins in the Regulation of Sepsis.Antioxidants (Basel, Switzerland) · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

José Pablo Vázquez-MedinaInstitute for Environmental Medicine, Department of Physiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Jian-Quin TaoInstitute for Environmental Medicine, Department of Physiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Priyal PatelInstitute for Environmental Medicine, Department of Physiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Renata Bannitz-FernandesInstitute for Environmental Medicine, Department of Physiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Chandra DodiaInstitute for Environmental Medicine, Department of Physiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Elena M SorokinaInstitute for Environmental Medicine, Department of Physiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Sheldon I FeinsteinInstitute for Environmental Medicine, Department of Physiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Shampa ChatterjeeInstitute for Environmental Medicine, Department of Physiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Aron B FisherInstitute for Environmental Medicine, Department of Physiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
University of Pennsylvania · US

Funding

Control of Calcium Release in Skeletal Muscle FibersR01AR055099 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI SCHNEIDER, MARTIN F · 2007 to 2011
$1.7M
The role of lysophosphatidic acid signaling in lung ischemia/reperfusion injuryF32HL127972 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI VAZQUEZ MEDINA, JOSE P · 2015 to 2016
$112k
NHLBI NIH HHS F32 HL127972NIAMS NIH HHS R01 AR055099
6 · The paper itself

Abstract

Peroxiredoxin 6 (Prdx6) is a multifunctional enzyme that serves important antioxidant roles by scavenging hydroperoxides and reducing peroxidized cell membranes. Prdx6 also plays a key role in cell signaling by activating the NADPH oxidase, type 2 (Nox2) through its acidic Ca

Indexed as

Acute Lung InjuryAmino Acid SubstitutionAnimalsCatalytic DomainDisease Models, AnimalLipopolysaccharidesMiceMice, Inbred C57BLMice, Mutant StrainsMice, TransgenicMutagenesis, Site-DirectedNADPH Oxidase 2Peroxiredoxin VIPhospholipase A2 InhibitorsPhospholipases A2Recombinant ProteinsCybb protein, mouselipopolysaccharide, Escherichia coli O111 B4LipopolysaccharidesNADPH Oxidase 2Peroxiredoxin VIPhospholipase A2 InhibitorsPhospholipases A2Prdx6 protein, mouseRecombinant Proteinsendothelial cellsMJ33mutant Prdx6NOX2 inhibitionPrdx6 phosphorylation

Identifiers

PMID30702344
PMCPMC6483013
OpenAlexW2913880639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.